Beneficial ownership — 13D / 13G
85,680 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.
Coverage begins December 2024, when the SEC required these schedules to be filed as structured XML.
| Reporting person | Issuer | Schedule | % of class | Event date | Filed |
|---|---|---|---|---|---|
| BAILLIE GIFFORD & CO | ABCL AbCellera Biologics Inc. | 13G/A | 8.29% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | AKLI Akili, Inc. Common Stock | 13G/A | 5.96% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | MRNA Moderna, Inc. | 13G/A | 11.97% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | DNA Ginkgo Bioworks Holdings, Inc. | 13G/A | 14.59% | Dec 29, 2023 | 2y |
| MITSUBISHI UFJ FINANCIAL GROUP INC | DESP Despegar.com, Corp. | 13G | 5% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | HCP HashiCorp, Inc. Class A Common Stock | 13G/A | 5.74% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | MBLY Mobileye Global Inc. | 13G/A | 8.9% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | JMIA Jumia Technologies AG | 13G/A | 9.2% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | JOBY Joby Aviation, Inc. | 13G | 8.09% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | NBTX Nanobiotix S.A. | 13G/A | 6.21% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | GH Guardant Health, Inc. | 13G | 5.24% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | DUOL Duolingo, Inc. | 13G/A | 10.04% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | AFRM Affirm Holdings, Inc. | 13G/A | 8.45% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | ADAPY Adaptimmune Therapeutics PLC | 13G/A | 7.01% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | LMND Lemonade, Inc. | 13G/A | 6.51% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | TXG 10x Genomics, Inc. | 13G/A | 7.6% | Dec 29, 2023 | 2y |
| BAILLIE GIFFORD & CO | MELI Mercadolibre Inc | 13G/A | 10.65% | Dec 29, 2023 | 2y |
| MERCHANT ADVENTURE FUND, L.P. | PLUR Pluri Inc. | 13G | 5.1% | Dec 5, 2023 | 2y |
| DONDERO JAMES D | NXRT NexPoint Residential Trust, Inc. | 13D/A | 11.8% | Sep 30, 2023 | 2y |
| Y.D. More Investments Ltd | DUKR DUKE Robotics Corp. | 13D/A | 42.61% | Apr 5, 2022 | 2y |
| KMBP Holdings Limited | SDA SunCar Technology Group Inc. | 13D/A | 23.6% | Jan 26, 2024 | 2y |
| TANG CAPITAL MANAGEMENT, LLC | CRBP Corbus Pharmaceuticals Holdings, Inc. | 13G | 9.6% | Jan 26, 2024 | 2y |
| Ridgeback Capital Investments L.P. | PYXS Pyxis Oncology, Inc. | 13G | 9.8% | Jan 26, 2024 | 2y |
| Michael Mo | KULR KULR Technology Group, Inc. | 13D/A | 15.9% | Jan 26, 2024 | 2y |
| James Huang | CASIF CASI Pharmaceuticals, Inc. | 13G/A | 19.99% | Jan 25, 2024 | 2y |
| Barry Sloane | NEWT NewtekOne, Inc. | 13D | 5.3% | Jan 25, 2024 | 2y |
| 22NW Fund, LP | FSTR Foster L B Co | 13D/A | 11.9% | Jan 25, 2024 | 2y |
| Robert F. Savage, Jr. | BAER Bridger Aerospace Group Holdings, Inc. | 13D/A | 7.5% | Jan 25, 2024 | 2y |
| Thomas Jermoluk | BAER Bridger Aerospace Group Holdings, Inc. | 13D/A | 1.7% | Jan 25, 2024 | 2y |
| Elliott Investment Management L.P. | SDRL SEADRILL Ltd | 13D/A | 8.1% | Jan 25, 2024 | 2y |
| Jeffrey E. Kelter | BAER Bridger Aerospace Group Holdings, Inc. | 13D/A | 7.5% | Jan 25, 2024 | 2y |
| Saba Capital Management, L.P. | ASA ASA Gold & Precious Metals Ltd | 13D/A | 16.87% | Jan 24, 2024 | 2y |
| Medicxi Growth I LP | PHAT Phathom Pharmaceuticals, Inc. | 13G/A | 13% | Jan 24, 2024 | 2y |
| EIG Veteran Equity Aggregator, L.P. | USAC USA Compression Partners, LP | 13D/A | 15.9% | Jan 24, 2024 | 2y |
| George Economou | SHIP Seanergy Maritime Holdings Corp. | 13D/A | 9.2% | Jan 24, 2024 | 2y |
| FIFTHDELTA Ltd | BB BLACKBERRY Ltd | 13G/A | 5.14% | Jan 24, 2024 | 2y |
| Saba Capital Management, L.P. | IGA Voya Global Advantage & Premium Opportunity Fund | 13D/A | 5.2% | Jan 24, 2024 | 2y |
| Soleus Capital Master Fund, L.P. | CALC CalciMedica, Inc. | 13G | 7.4% | Jan 23, 2024 | 2y |
| Divisadero Street Capital Management, LP | RSI Rush Street Interactive, Inc. | 13G | 5.9% | Jan 22, 2024 | 2y |
| FIFTHDELTA Ltd | BB BLACKBERRY Ltd | 13G/A | 4.85% | Jan 22, 2024 | 2y |
| Farhad Fred Ebrahimi | SSYS Stratasys Ltd. | 13D | 5.13% | Jan 19, 2024 | 2y |
| Farhad Fred Ebrahimi | FSLR First Solar, Inc. | 13D | 5.1% | Jan 19, 2024 | 2y |
| Nelson Michael Aaron | BLPH Bellerophon Therapeutics, Inc. | 13G | 5.3% | Jan 16, 2024 | 2y |
| Deep Track Capital, LP | ALLK Allakos Inc. | 13G | 5.72% | Jan 16, 2024 | 2y |
| BlackRock Inc. | LXU Lsb Industries, Inc. | 13G/A | 7.5% | Dec 31, 2023 | 2y |
| BlackRock Inc. | ESAB ESAB Corp | 13G/A | 7.9% | Dec 31, 2023 | 2y |
| BlackRock Inc. | BBWI Bath & Body Works, Inc. | 13G/A | 7.2% | Dec 31, 2023 | 2y |
| BlackRock Inc. | EBC Eastern Bankshares, Inc. | 13G/A | 7.1% | Dec 31, 2023 | 2y |
| BlackRock Inc. | SBGI Sinclair, Inc. | 13G | 6.9% | Dec 31, 2023 | 2y |
| BlackRock Inc. | ACCD Accolade, Inc. Common Stock | 13G/A | 7.4% | Dec 31, 2023 | 2y |